Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Controlled self-assembly of a pyrene-based bolaamphiphile by acetate ions: from nanodisks to nanofibers by fluorescence enhancement.

Soft matter·2015
Same author

Gradual-order enhanced stability: a frozen section of electrospun nanofibers for energy storage.

Nanoscale·2015
Same author

[Association of human epicardial adipose tissue volume and inflammatory mediators with atherosclerosis and vulnerable coronary atherosclerotic plaque].

Zhonghua xin xue guan bing za zhi·2015
Same author

Ultrasensitive SERS detection of trinitrotoluene through capillarity-constructed reversible hot spots based on ZnO-Ag nanorod hybrids.

Nanoscale·2015
Same author

pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.

World journal of surgical oncology·2015
Same author

Probing and controlling liquid crystal helical nanofilaments.

Nano letters·2015

相关实验视频

Updated: Feb 21, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K

构建优化使型病毒介导的功能性膜局部化,卡尔雷蒂库林和巨重编程成为可能.

Xinyuan Zhang1,2, Shengfeng Xiong1,2, Song Zhang1,2

  • 1Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Human gene therapy
|February 19, 2026
PubMed
概括

研究人员设计了一种瘤性腺病毒 (oAd) 来表达calreticulin (CALR),增强瘤细胞溶解并刺激抗瘤免疫反应. 这种优化的病毒疗法通过调节瘤微环境,有望改善癌症免疫疗法.

关键词:
卡尔雷蒂库林是一种卡尔雷蒂库林.巨细胞的两极分化型瘤性腺病毒

更多相关视频

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.7K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.5K

相关实验视频

Last Updated: Feb 21, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.7K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.5K

科学领域:

  • 瘤治疗性病毒疗法
  • 癌症免疫疗法癌症免疫疗法
  • 免疫调节是一种免疫调节.

背景情况:

  • 瘤病毒被设计成可以选择性地感染和杀死癌细胞.
  • 增强病毒平台以改善瘤向和免疫刺激至关重要.
  • 对瘤细胞的卡尔雷蒂库林 (CALR) 暴露可以促进免疫识别和抗瘤反应.

研究的目的:

  • 为优化瘤性腺病毒 (oAd) 增强瘤细胞溶解和免疫调节.
  • 在oAd平台中确定calreticulin (CALR) 表达的最佳插入位.
  • 研究oAd介导的CALR表达的机制及其对免疫细胞和瘤生长的功能影响.

主要方法:

  • 在型腺病毒中对CALR插入部位的系统探索.
  • 对oAd的基因工程包括E1A CR2删除和E3-gp19k用CMV促进物替换.
  • 大量RNA测序 (RNA-Seq) 用于分析转染后的基因表达变化.
  • 活体培试验测定了巨细胞和来自患者的卵巢癌球体.
  • 在小鼠中使用Hepa1-6异种移植模型的体内研究.

主要成果:

  • 确定了一种最佳的oAd变体 (oAd-CMV-CALR),有效地在瘤细胞膜上表达CALR.
  • oAd-CMV-CALR诱导了内质网膜应激和在视网母细胞瘤缺陷瘤细胞中的选择性复制.
  • 感染过的巨细胞显示了增强的细胞能力和M1类复极化.
  • 在体内研究表明抑制瘤生长,增加CD8+T细胞透,以及良好的安全性.
  • 该方法显示了患者衍生卵巢癌球体的翻译潜力.

结论:

  • oAd-CMV-CALR代表了癌症免疫治疗的有前途的治疗策略.
  • 这种工程病毒有效地将直接杀死瘤细胞与强大的免疫系统激活相结合.
  • 这些发现突出了oAd-CMV-CALR调节瘤微环境并改善治疗结果的潜力.